e-Drug3D

1351

STANOZOLOL

DISCONTINUED


INN
STANOZOLOL

cas 10418-03-8
CLASS

METABOLISM
ANABOLIC STEROID
ANDROGENIC AGONIST

ROUTE (list)

ORAL

ATC code

A14AA02

PK parameters

Target

TARGET ESTROGEN RECEPTOR (PMID22906881)
ANDROGEN RECEPTOR

DrugCentral

Androgen receptor UNIPROT P10275 AR

Download SDF file 2'H-Androst-2-eno[3,2-c]pyrazol-17-ol, 17-methyl-, (5.alpha.,17.beta.)-

Formula:
C21H32N2O

Calculated chemical properties:

MW 328.49
NB_atoms 24
XLogP 4.12
PSA 47.586
NB_HD 2
NB_HA 3
fsp3 0.86
Lipinski(0=no;1=yes) 1

FDA
NDA 012885 (pdf not found) INN (STANOZOLOL) WINSTROL (LUNDBECK INC) APPROVAL= AP YEAR= 1962 DISCONTINUED

Other links:

PubChem
ChemicalProbes

U.S. repository of Clinical Trials

VigiAccess
SIDER side effects

ChemSynthesis
Patent@SureChEMBL